1. Home
  2. ENVB vs WLDS Comparison

ENVB vs WLDS Comparison

Compare ENVB & WLDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • WLDS
  • Stock Information
  • Founded
  • ENVB 1994
  • WLDS 2014
  • Country
  • ENVB United States
  • WLDS Israel
  • Employees
  • ENVB N/A
  • WLDS N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • WLDS Computer Communications Equipment
  • Sector
  • ENVB Health Care
  • WLDS Telecommunications
  • Exchange
  • ENVB Nasdaq
  • WLDS Nasdaq
  • Market Cap
  • ENVB 3.1M
  • WLDS 3.4M
  • IPO Year
  • ENVB N/A
  • WLDS 2022
  • Fundamental
  • Price
  • ENVB $1.32
  • WLDS $1.54
  • Analyst Decision
  • ENVB Strong Buy
  • WLDS
  • Analyst Count
  • ENVB 1
  • WLDS 0
  • Target Price
  • ENVB $10.00
  • WLDS N/A
  • AVG Volume (30 Days)
  • ENVB 107.1K
  • WLDS 445.8K
  • Earning Date
  • ENVB 08-11-2025
  • WLDS 01-01-0001
  • Dividend Yield
  • ENVB N/A
  • WLDS N/A
  • EPS Growth
  • ENVB N/A
  • WLDS N/A
  • EPS
  • ENVB N/A
  • WLDS N/A
  • Revenue
  • ENVB N/A
  • WLDS $522,000.00
  • Revenue This Year
  • ENVB N/A
  • WLDS N/A
  • Revenue Next Year
  • ENVB N/A
  • WLDS N/A
  • P/E Ratio
  • ENVB N/A
  • WLDS N/A
  • Revenue Growth
  • ENVB N/A
  • WLDS 536.59
  • 52 Week Low
  • ENVB $1.01
  • WLDS $1.20
  • 52 Week High
  • ENVB $11.55
  • WLDS $45.32
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 57.52
  • WLDS 49.16
  • Support Level
  • ENVB $1.19
  • WLDS $1.46
  • Resistance Level
  • ENVB $1.28
  • WLDS $1.62
  • Average True Range (ATR)
  • ENVB 0.06
  • WLDS 0.16
  • MACD
  • ENVB 0.02
  • WLDS 0.01
  • Stochastic Oscillator
  • ENVB 91.48
  • WLDS 19.92

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

Share on Social Networks: